Ep. 1180: Paul Mulvaney Interview with Michael Covel on Trend Following Radio

Originally broadcast May 15, 2023

---

My guest today is Paul Mulvaney, known as the trend following trader who made over 100 percent in 2008. He graduated from Manchester University in 1985 with a First Class Honours degree in Computer Science & Mathematics. He completed the one-year Management Science program at Imperial College, London in 1986, earning an MSc with Distinction. The focus of his Master’s thesis was computerized arbitrage models for interest and exchange rate trading. After university, Paul held posts in derivatives and foreign exchange trading at Midland Montagu, Bankers Trust Company and NatWest Markets before joining Merrill Lynch in September 1993. At Merrill Lynch, he managed several of the firm’s major options portfolios, including Global Foreign Exchange Options and Exotic Commodity Options. Paul left Merrill Lynch in 1999 and then founded Mulvaney Capital.

The topic is Trend Following.

In this episode of Trend Following Radio we discuss:
▪️ Trading systems
▪️ Trend following strategy
▪️ Writing simulations
▪️ Major trends

Jump in!

---

I’m MICHAEL COVEL, the host of TREND FOLLOWING RADIO, and I’m proud to have delivered 10+ million podcast listens since 2012. Investments, economics, psychology, politics, decision-making, human behavior, entrepreneurship and trend following are all passionately explored and debated on my show.

My social media platforms:
Twitter: @covel
Facebook: @trendfollowing
LinkedIn: @covel
Instagram: @mikecovel

Hope you enjoy my never-ending podcast conversation!

[bandidobrazo]

At 3:46, did Paul say that the only inputs to the system are ”price points" or something else entirely?

[johngreydanus]

Now this is what you call a spectacular start to the year.

Mulvaney Capital Management’s Global Markets Fund posted a hard-to-believe 51 percent gain in March 2024. As a result, the fund headed by Paul Mulvaney is up 124.41 percent for the first quarter, according to the firm’s March client tear sheet, seen by Institutional Investor.